PTI

Proteostasis
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.280
+0.030
+2.40%
After Hours: 1.310 +0.03 +2.34% 17:44 03/27 EDT
OPEN
1.250
PREV CLOSE
1.250
HIGH
1.310
LOW
1.120
VOLUME
372.11K
TURNOVER
--
52 WEEK HIGH
4.720
52 WEEK LOW
0.6100
MARKET CAP
66.75M
P/E (TTM)
-1.1068
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of PTI and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average PTI stock price target is 5.50 with a high estimate of 8.00 and a low estimate of 3.000.

EPS

PTI News

More
  • RDS.A, NRZ among premarket gainers
  • Seeking Alpha - Article · 03/19 13:20
  • Proteostasis Therapeutics EPS beats by $0.06
  • seekingalpha · 03/11 01:41
  • Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
  • PR Newswire · 03/10 21:36
  • Proteostasis Says Sees Dosing In CHOICES Trial Expected To Begin H2'20, Sees Prelim. Clinical Data Early '21
  • Benzinga · 03/10 20:42

Industry

Biotechnology & Medical Research
-2.43%
Pharmaceuticals & Medical Research
-0.87%

Hot Stocks

Symbol
Price
%Change

About PTI

Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company. The Company is engaged in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network, a set of pathways that control protein biosynthesis, folding, trafficking and clearance. The Company focuses on identifying therapies that restore protein function. The Company’s CF focused pipeline consists of novel CFTR modulators including correctors, potentiators and amplifiers. The Company’s clinical developments include PTI-801, a third generation CFTR corrector, PTI-808, a CFTR potentiator, and PTI-428, a CFTR amplifier.
More

Webull offers kinds of Proteostasis Therapeutics Inc stock information, including NASDAQ:PTI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PTI stock news, and many more online research tools to help you make informed decisions.